- Report
- August 2025
- 184 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- September 2025
- 197 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- August 2025
- 144 Pages
Global
From €2549EUR$2,900USD£2,205GBP
- Report
- April 2025
- 144 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP
- Report
- August 2025
- 148 Pages
Global
From €2549EUR$2,900USD£2,205GBP
- Report
- March 2025
- 78 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- August 2025
- 195 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 184 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- January 2025
- 250 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- September 2025
- 187 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- August 2025
- 190 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 195 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 184 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 185 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 195 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- September 2025
- 179 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- April 2022
- 228 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- July 2024
- 146 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- June 2022
- 80 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- March 2023
- 151 Pages
Global
From €3129EUR$3,560USD£2,707GBP
€3911EUR$4,450USD£3,383GBP

The Human Milk Oligosaccharides (HMOs) market is a segment of the Vitamins and Dietary Supplements industry. HMOs are a type of prebiotic found in human breast milk, and are believed to have a range of health benefits. They are used in a variety of products, including infant formula, dietary supplements, and functional foods.
HMOs are gaining popularity due to their potential to improve gut health, boost immunity, and reduce the risk of certain diseases. They are also being studied for their potential to improve cognitive development in infants.
The HMOs market is driven by increasing awareness of the health benefits of HMOs, as well as the growing demand for infant formula and dietary supplements. The market is expected to grow in the coming years, as more research is conducted on the potential health benefits of HMOs.
Some companies in the Human Milk Oligosaccharides market include Abbott Nutrition, Nestle, Danone, FrieslandCampina, and Mead Johnson Nutrition. Show Less Read more